238 related articles for article (PubMed ID: 18035682)
1. [CUP syndrome: are there advances?].
Moll R
Verh Dtsch Ges Pathol; 2005; 89():125-36. PubMed ID: 18035682
[TBL] [Abstract][Full Text] [Related]
2. Carcinoma of unknown primary (CUP).
Pavlidis N; Fizazi K
Crit Rev Oncol Hematol; 2009 Mar; 69(3):271-8. PubMed ID: 18977667
[TBL] [Abstract][Full Text] [Related]
3. Solid neuroendocrine breast carcinomas: incidence, clinico-pathological features and immunohistochemical profiling.
López-Bonet E; Alonso-Ruano M; Barraza G; Vazquez-Martin A; Bernadó L; Menendez JA
Oncol Rep; 2008 Dec; 20(6):1369-74. PubMed ID: 19020716
[TBL] [Abstract][Full Text] [Related]
4. Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary tumor site.
Hainsworth JD; Greco FA
Semin Oncol; 1993 Jun; 20(3):279-86. PubMed ID: 8503024
[TBL] [Abstract][Full Text] [Related]
5. [Unknown primary cancer].
Furue H
Gan To Kagaku Ryoho; 1998 Jan; 25(1):1-6. PubMed ID: 9464322
[TBL] [Abstract][Full Text] [Related]
6. [The CUP syndrome--malignant disease with unknown primary tumor. Part 2: Histology--immunohistology].
Jaspersen D
Fortschr Med; 1992 Oct; 110(29):541-2. PubMed ID: 1385284
[No Abstract] [Full Text] [Related]
7. Carcinoma of unknown primary (CUP); some considerations about pathogenesis and diagnostic strategy, particularly focusing on CUPS pertaining to the Urology.
Alberti C
G Chir; 2012; 33(1-2):41-6. PubMed ID: 22357439
[TBL] [Abstract][Full Text] [Related]
8. [The initial CUP situation and CUP syndrome: pathological diagnostics].
Moll R
Pathologe; 2009 Dec; 30 Suppl 2():161-7. PubMed ID: 19816686
[TBL] [Abstract][Full Text] [Related]
9. Cancer of unknown primary site: missing primary or missing biology?
Pentheroudakis G; Briasoulis E; Pavlidis N
Oncologist; 2007 Apr; 12(4):418-25. PubMed ID: 17470684
[TBL] [Abstract][Full Text] [Related]
10. Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm.
Dennis JL; Hvidsten TR; Wit EC; Komorowski J; Bell AK; Downie I; Mooney J; Verbeke C; Bellamy C; Keith WN; Oien KA
Clin Cancer Res; 2005 May; 11(10):3766-72. PubMed ID: 15897574
[TBL] [Abstract][Full Text] [Related]
11. [Differential diagnosis of primary lung tumors and pulmonary metastases].
Fisseler-Eckhoff A; Müller KM
Verh Dtsch Ges Pathol; 2000; 84():106-17. PubMed ID: 11217430
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of cancer of unknown primary, today and future].
Shibata H
Gan To Kagaku Ryoho; 2009 Jun; 36(6):918-22. PubMed ID: 19542712
[TBL] [Abstract][Full Text] [Related]
13. Switching benchmarks in cancer of unknown primary: from autopsy to microarray.
Pentheroudakis G; Golfinopoulos V; Pavlidis N
Eur J Cancer; 2007 Sep; 43(14):2026-36. PubMed ID: 17698346
[TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical identification of carcinomas of unknown primary in serous effusions.
Pomjanski N; Grote HJ; Doganay P; Schmiemann V; Buckstegge B; Böcking A
Diagn Cytopathol; 2005 Nov; 33(5):309-15. PubMed ID: 16240395
[TBL] [Abstract][Full Text] [Related]
15. Cancer of unknown primary (CUP).
Pavlidis N; Fizazi K
Crit Rev Oncol Hematol; 2005 Jun; 54(3):243-50. PubMed ID: 15890271
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical panel of undifferentiated orbital metastatic carcinomas.
Godeiro KD; Odashiro AN; Odashiro DN; Fernandes BF; Burnier MN; Callejo S
Orbit; 2007 Jun; 26(2):101-6. PubMed ID: 17613856
[TBL] [Abstract][Full Text] [Related]
17. [Cancer of unknown primary site origin--advances in diagnosis and therapy].
Plot L; Dovrish Z; Hadari R; Weisenberg N; Zehavi T; Nisenbaum B; Amital H
Harefuah; 2008 Apr; 147(4):294-8, 376, 375. PubMed ID: 18686808
[TBL] [Abstract][Full Text] [Related]
18. The role of L1-CAM immunohistochemial staining in the diagnosis of abdominal-pelvic cancer of uncertain primary site in women.
Ben-Arie A; Huszar M; Ben-Zvi N; Smirnov A; Altevogt P; Fogel M
Eur J Surg Oncol; 2008 Jul; 34(7):795-9. PubMed ID: 17845837
[TBL] [Abstract][Full Text] [Related]
19. [The CUP syndrome--malignant disease with unknown primary tumor. Part 3: Metastatic site--tumor markers].
Jaspersen D
Fortschr Med; 1992 Nov; 110(30):562-4. PubMed ID: 1468742
[No Abstract] [Full Text] [Related]
20. Neuroendocrine carcinoma of unknown primary site.
Spigel DR; Hainsworth JD; Greco FA
Semin Oncol; 2009 Feb; 36(1):52-9. PubMed ID: 19179188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
